Genes Encoding Multiple Modulators of the Immune Response Are Methylated in the Prostate Tumor Microenvironment of African Americans
Authors:
- Vinay KumarVKVinay Kumar
- Tara Sinta Kartika JenningsTJTara Sinta Kartika Jennings
- Lucas UetaLULucas Ueta
- James NguyenJNJames Nguyen
- Liankun SongLSLiankun Song
- Michael McClellandMMMichael McClelland
- Weiping ChuWCWeiping Chu
- Michael LillyMLMichael Lilly
- Michael IttmannMIMichael Ittmann
- Patricia CastroPCPatricia Castro
- Arash Rezazadeh KalebastyAKArash Rezazadeh Kalebasty
- Dan MercolaDMDan Mercola
Open Access
Abstract
Background/Objectives: Prostate cancer (PCa) is diagnosed at an earlier median age, more advanced stage, and has worse clinical outcomes in African American (AA) men compared to European Americans (EA). Methods: To investigate the role of aberrant DNA methylation in tumor-adjacent stroma (TAS), methyl binding domain sequencing (MBD-seq) was performed on AA (n = 17) and EA (n = 15) PCa patients. This was independently confirmed using the long interspersed nuclear element-1 (LINE-1) assay. Pathway analysis was performed on statistically significantly differentially methylated genes for AA and EA TAS. DNA methylation profiles of primary cultured AA and EA carcinoma-associated fibroblasts (CAFs) were compared with AA and EA TAS. AA and EA CAFs were treated with demethylating agent 5-Azacytidine (5-AzaC). Results: AA TAS exhibited higher global DNA methylation than EA TAS (p-value < 0.001). Of the 3268 differentially methylated regions identified (DMRs, p-value < 0.05), 85% (2787 DMRs) showed increased DNA methylation in AA TAS, comprising 1648 genes, of which 1379 were protein-coding genes. Based on DNA methylation levels, two AA subgroups were identified. Notably, AA patients with higher DNA methylation were predominantly those with higher Gleason scores. Pathway analysis linked methylated genes in AA TAS to several key signaling pathways (p-value < 0.05), including immune response (e.g., IL-1, IL-15, IL-7, IL-8, IL-3, and chemokine), Wnt/β-catenin, androgen, PTEN, p53, TGF-β, and circadian clock regulation. A total of 168 concordantly methylated genes were identified, with 109 genes (65%) showing increased methylation in AA CAFs and TAS (p-value < 0.05). Treatment with 5-AzaC significantly reduced DNA methylation of concordant genes in AA CAFs (p-value < 0.001). Conclusions: These findings suggest a distinct stromal methylome in AA, providing a foundation for integrating demethylating agents into standard therapies. This approach targets the tumor microenvironment, potentially addressing PCa disparities in AA men.Keywords
Funding Information
- NIH/NCI (R01CA226570, 56 /IRG-16-187-13, NCI-CA125123, R01CA260351)
- Baylor College of Medicine Human Tissue & Pathology Core (R01CA226570, 56 /IRG-16-187-13, NCI-CA125123, R01CA260351)
This publication has 52 references indexed in Scilit:
- Genome‐wide methylation profiling of diagnostic tumor specimens identified DNA methylation markers associated with metastasis among men with untreated localized prostate cancerCancer Medicine, 2023
- The importance of DNA methylation in prostate cancer developmentThe Journal of Steroid Biochemistry and Molecular Biology, 2017
- SFRP1 repression in prostate cancer is triggered by two different epigenetic mechanismsGene, 2016
- Epigenetic switch drives the conversion of fibroblasts into proinvasive cancer-associated fibroblastsNature Communications, 2015
- Expression differences between African American and Caucasian prostate cancer tissue reveals that stroma is the site of aggressive changesInternational Journal of Cancer, 2013
- Differential oestrogen receptor binding is associated with clinical outcome in breast cancerNature, 2012
- A decade of exploring the cancer epigenome — biological and translational implicationsNature Reviews Cancer, 2011
- Using MACS to Identify Peaks from ChIP‐Seq DataCurrent Protocols in Bioinformatics, 2011
- Quantitative Assessment of AKAP12 Promoter Methylation in Human Prostate Cancer Using Methylation-sensitive High-resolution Melting: Correlation With Gleason ScoreUrology, 2011
- Stromal fibroblasts in cancer initiation and progressionNature, 2004